Spondyloarthritis: How JAK inhibitor and TNF inhibitor drugs are helping in SpA

Speciality: Orthopedics

Description:

A warm welcome to all the medical professionals in this interesting session on use of JAK inhibitor and TNF inhibitor drugs in spondyloarthritis. We have Dr. Jyotsna Oak, Dr. Shashank Akerkar and Dr. Sourabh Malviya to lead the session.

Spondyloarthritis is a type of arthritis where the spine is affected and, in some cases, the joints of the arms and legs are also affected. It can also involve the skin, intestines and eyes. The primary symptom observed in most patients is low back pain, mostly axial spondyloarthritis. 

It is thought that spondyloarthritis develops through the interaction of genetic and environmental factors. Further, spondyloarthropathies (SpA) is recognised as autoimmune disease as it is strongly associated with HLA-B27, a gene variant that controls immune responses. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars